1. 112 RANDOMIZED PHASE III STUDY OF IV RIGOSERTIB VERSUS BEST SUPPORTIVE CARE (BSC) IN PATIENTS WITH HIGHER-RISK MDS (HR-MDS) AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS). (April 2015) Authors: Garcia-Manero, G.; Fenaux, P.; Al-Kali, A.; Baer, M.R.; Sekeres, M.; Roboz, G.; Gaidano, G.; Scott, B.; Greenberg, P.; Platzbecker, U.; Steensma, D.P.; Kambhampati, S.; Kreuzer, K.A.; Godley, L.; Collins, R.; Atallah, E.; Azarnia, N.; Petrone, M.E.; Snyder, B.R.; Maniar, M. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 396 CD8+ T CELLS AS IMMUNOGENIC VACCINE VEHICLES. (1st January 2004) Authors: Shur, A.; Hsing, L.; Yang, Y.; Dossett, M.; Ohlen, C.; Riddell, S.; Greenberg, P. Journal: Journal of investigative medicine Issue: Volume 52(2004)Supplement 1 Page Start: S148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 74 CD8+ T CELLS AS IMMUNOGENIC VACCINE VEHICLES. (1st January 2004) Authors: Shur, A.; Hsing, L.; Yang, Y.; Dossett, M.; Ohlen, C.; Riddell, S.; Greenberg, P. Journal: Journal of investigative medicine Issue: Volume 52(2004)Supplement 1 Page Start: S91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 88 BONE MARROW BLAST (BMBL) RESPONSE CORRELATES WITH OVERALL SURVIVAL IN RIGOSERTIB-TREATED PATIENTS WITH HIGHER-RISK MDS AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS): A NEW RESPONSE CRITERION?. (April 2015) Authors: Silverman, L.R.; Fenaux, P.; Al-Kali, A.; Baer, M.R.; Sekeres, M.; Roboz, G.; Gaidano, G.; Scott, B.; Greenberg, P.; Platzbecker, U.; Steensma, D.P.; Kambhampati, S.; Kreuzer, K.A.; Godley, L.; Collins, R.; Atallah, E.; Navada, S.C.; Azarnia, N.; Garcia-Manero, G. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Contemporary Analysis of Medicolegal Issues in Obstetric Anesthesia Between 2005 and 2015. Issue 1 (March 2020) Authors: Kovacheva, V.P.; Brovman, E.Y.; Greenberg, P.; Song, E.; Palanisamy, A.; Urman, R.D. Journal: Obstetric anesthesia digest Issue: Volume 40:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Chromosomal Aberrations in Therapy-Related Myelodysplastic Syndromes – Relations to Primary Disease, Therapy and Prognostic Significance. (April 2017) Authors: Nomdedeu, M.; Tuechler, H.; Kuendgen, A.; Solé, F.; Schanz, J.; Hildebrandt, B.; Grau, J.; Pereira, A.; García-Manero, G.; Sekeres, M.A.; Komrokji, R.S.; Voso, M.T.; List, A.F.; Cazzola, M.; Sill, H.; Stauder, R.; Greenberg, P.; Germing, U.; Sanz, G.; Haase, D. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): GENOMIC CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES. (May 2023) Authors: Bernard, E.; Hasserjian, R.; Greenberg, P.; Ossa, J. Arango; Creignou, M.; Nannya, Y.; Tuechler, H.; Medina-Martinez, J.; Levine, M.; Jädersten, M.; Germing, U.; Sanz, G.; Van De Loosdrecht, A.; Kosmider, O.; Follo, M.; Thol, F.; Zamora, L.; Pinheiro, R.; Pellagatti, A.; Elias, H. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Topic: AS02-Epidemiology: COMPARISON OF CYTOGENETIC ABERRATIONS IN 1590 PATIENTS WITH THERAPY-RELATED MDS (T-MDS) AND 4738 PATIENTS FROM THE REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM DATABASE WITH PRIMARY-MDS (P-MDS). (September 2021) Authors: Kuendgen, A.; Nomdedeu, M.; Tuechler, H.; Garcia-Manero, G.; Komrokji, R.; Sekeres, M.; Della Porta, M.; Cazzola, M.; Malcovati, L.; Dezern, A.; Roboz, G.; Steensma, D.; Haase, D.; Stauder, R.; Cedena, M.T.; Van De Loosdrecht, A.; Schlenk, R.; Blum, S.; Grau, J.; Calvo, X. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: A STEP TOWARDS IDENTIFICATION AND CAUSAL INTERPRETATION OF THERAPY-RELATED MDS (T-MDS). (May 2023) Authors: Kuendgen, A.; Nomdedeu, M.; Tuechler, H.; Garcia-Manero, G.; Komrokji, R.; Sekeres, M.; Della Porta, M.; Cazzola, M.; Dezern, A.; Roboz, G.; Steensma, D.; Van De Loosdrecht, A.; Malcovati, L.; Schlenk, R.; Grau, J.; Calvo, X.; Blum, S.; Pereira, A.; Valent, P.; Costa, D. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: ACCELERATED FAILURE TIME MODELS AS A CLINICALLY PLAUSIBLE WAY TO DESCRIBE SURVIVAL IN MDS – AN ANALYSIS OF THE IWG-PM DATABASE. (May 2023) Authors: Pfeilstöcker, M.; Tuechler, H.; Ades, L.; Cermak, J.; Chermat, F.; Della Porta, M.; Fenaux, P.; Garcia-Manero, G.; Germing, U.; Haase, D.; Kündgen, A.; Lübbert, M.; Magalhaes, S.; Malcovati, L.; Miyazaki, Y.; Sanz, G.; Santini, V.; Sekeres, M.; Walter, M.; Valent, P. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗